Compare BSAC & RVTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BSAC | RVTY |
|---|---|---|
| Founded | 1977 | 1937 |
| Country | Chile | United States |
| Employees | N/A | N/A |
| Industry | Commercial Banks | Biotechnology: Laboratory Analytical Instruments |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.6B | 11.8B |
| IPO Year | 2002 | 1994 |
| Metric | BSAC | RVTY |
|---|---|---|
| Price | $31.77 | $87.12 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 2 | 15 |
| Target Price | $29.50 | ★ $113.00 |
| AVG Volume (30 Days) | 388.4K | ★ 978.4K |
| Earning Date | 04-29-2026 | 04-27-2026 |
| Dividend Yield | ★ 3.06% | 0.32% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 2.07 |
| Revenue | N/A | ★ $3,311,822,000.00 |
| Revenue This Year | $36.86 | $6.34 |
| Revenue Next Year | $7.32 | $5.10 |
| P/E Ratio | ★ $14.40 | $42.45 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $20.77 | $81.36 |
| 52 Week High | $37.72 | $118.30 |
| Indicator | BSAC | RVTY |
|---|---|---|
| Relative Strength Index (RSI) | 45.28 | 38.12 |
| Support Level | $29.41 | $83.11 |
| Resistance Level | $33.36 | $88.60 |
| Average True Range (ATR) | 0.92 | 2.72 |
| MACD | 0.15 | 0.34 |
| Stochastic Oscillator | 47.67 | 38.87 |
Founded in 1978, Banco Santander Chile is part of Santander Group and majority-controlled by Santander Spain. It is the largest bank in Chile by loans and the second largest by deposits. The bank generates most of its net interest income (roughly 65% of total revenue) from its mortgages, unsecured consumer credit lines, and commercial loans. Banco Santander's commercial loan business is more focused on small- to medium-size companies, with firms generating more than CLP 10,000 million in revenue only making up around 5% of outstanding loans. Outside of lending, Banco Santander is the largest card issuer in the country with around 25% of the market and benefits from a long-term strategic partnership with the largest airline in the country, LATAM.
Revvity is a global life sciences and diagnostics company formed in 2023 following the rebranding of PerkinElmer. The company operates in two segments: life sciences, which provides reagents and instruments for biopharma and academic research, and signals software, and diagnostics, which offers tools in immunodiagnostics and newborn and reproductive health. Revvity's products and services are sold worldwide, with major markets in the US, Europe, and China.